We would love to hear your thoughts about our site and services, please take our survey here.
Kainos,
Why invest in BRH, if you are spreading rumours about the CEO of this Company?
If so wished, invest and keep your cool.
All LTHs are happy and major investment are held by PI and Traders and IIs.
Hereafter if you post rumours here in this board, we may have to filer you or tell LSE to block you.
bbrq648
LTH,
Looks like demands are high and allowing to sell in IWEB, but buys donāt go into auto trade display prices.
Hold on to your valuable shares, and maximum only two weeks prior to receipt of many interesting RNSs from BRH.
bbrq648
Why BRH/ Paraytec Test is best currently in the world, undergoing Clinical Validation?
Clinical validation is going successfully and about to complete before end of April 2021.
Just a couple of weeks only left.
The deficiencies of the LFT and RT-PCR tests have been known to Paraytec and Prof. Carl Smythe and his team.
During the Fast track Paraytec LFT and Multiplex Matrix Test Development, the Test performance have taken into consideration of sensitivity and specificity as well as the presence of level of viral load to lower levels to pick-up pre-symptomatic and asymptomatic persons identified and isolated in advance to stop spreading the COVID-19 viruses in public places.
As the symptomatic cases have high viral load had good detection with false negative and false positives. These issues were also addressed during the BRH/ Paraytec Test development.
Furthermore, proper and easy sampling techniques put in place to identify tests are invalid cases, and to repeat the test. This will be addressed in the sampling technique to be used for both the tests.
DHSC had tightened the testing ranges and viral loads to pick-up pre-symptomatic and asymptomatic cases more accurately in their latest specification.
BRH RNSs dated 01-Mar-2021 and 26-Mar-2021 clearly stated the interim trial test conducted, and refined as appropriate to meet or exceed the DHSC specific requirements.
Thus, even with the delay in testing and with additional platform technology to potentially identify/ detect multiple virus targets will be the only market leader in Fast, Accurate and Sensitive test available very soon.
Forecast date: Before or End of April 2021.
Even with a month delay, this BRH/Paraytec Test is going to be the market leader.
With UKCA, CE, FDA approvals, PHA Test Validation, Approvals, Partner(s), Manufacturers licences and Contracts are still outstanding and will be forthcoming in successive RNSs from BRH/Paraytec.
This is a buying opportunity with the unusual price fluctuation yesterday. LTHs have made use of 62p drop and bought them. Those who bought yesterday, please hold them till the share price to move back to Ā£1.40 and then gradually move northward (increase) with steady positive news.
By then the Alzheimerās and Sepsis Tests would progress successfully to further increase in BRH share value.
Good Luck to LTH.
bbrq648
Few derampers still left for fishing here.
Leave the PI and this board alone, and the BRH/ Paraytec LFT and Matrix Testing is going to clear the issues related to the existing LFTs which cannot resolve False Positive and False Negative Tests.
I will post why BRH/ Paraytec is going to be the Gold Standard LFTs and better than PCR Test as well.
bbrq648
Why is price drop suddenly with less than 10000 & 40000?
Whereas more than 500,000 share sale price was static.
Can the MM explain why, and if there are large sales from Insiders, will the TR1 forthcoming early morning at 7:00AM?
If it is a normal sale, then this would have been reflected in the BRH L2 as well as daily buys and sells. Even though the share price algorithm is automatically setting the price, some additional information missing for the PIs, and not shown in the buys & sells.
Correction needed in the BRH L2 display console.
bbrq648
bbrq648
HeresHopin,
If you have shares then either average down or stay safe.
Donāt post saying Rampers.
LTH are watching and making use of share price movements and either average down or not topping up.
bbrq648
DrMicho,
Fact of the matter is all the sells were bought yesterday by LTH, Traders and IIs.
Most of us in this BB knows an RNS will make its way 2nd day, i.e., tomorrow if this was insider trading.
bbrq648
The deficiencies of the LFT and RT-PCR tests have been known to Paraytec and Prof. Carl Smythe and his team.
During the Fast track Paraytec LFT and Multiplex Matrix Test Development, the Test performance have taken into consideration of sensitivity and specificity as well as the presence of level of viral load to lower levels to pick-up pre-symptomatic and asymptomatic persons identified and isolated in advance to stop spreading the COVID-19 viruses in public places.
As the symptomatic cases have high viral load had good detection with false negative and false positives. These issues were also addressed during the BRH/ Paraytec Test development.
Furthermore, proper and easy sampling techniques put in place to identify tests are invalid cases, and to repeat the test. This will be addressed in the sampling technique to be used for both the tests.
DHSC had tightened the testing ranges and viral loads to pick-up pre-symptomatic and asymptomatic cases more accurately in their latest specification.
BRH RNSs dated 01-Mar-2021 and 26-Mar-2021 clearly stated the interim trial test conducted, and refined as appropriate to meet or exceed the DHSC specific requirements.
Thus, even with the delay in testing and with additional platform technology to potentially identify/ detect multiple virus targets will be the only market leader in Fast, Accurate and Sensitive test available very soon.
Forecast date: Before or End of April 2021.
Even with a month delay, this BRH/Paraytec Test is going to be the market leader.
With UKCA, CE, FDA approvals, PHA Test Validation, Approvals, Partner(s), Manufacturers licences and Contracts are still outstanding and will be forthcoming in successive RNSs from BRH/Paraytec.
This is a buying opportunity with the unusual price fluctuation yesterday. LTHs have made use of 62p drop and bought them. Those who bought yesterday, please hold them till the share price to move back to Ā£1.40 and then gradually move northward (increase) with steady positive news and RNSs.
By then the Alzheimerās and Sepsis Tests would progress successfully to further increase in BRH share value.
Good Luck to LTH.
bbrq648
As of 4/12, 6.8m+ doses of the J&J vaccine have been administered in the U.S. CDC & FDA are reviewing data involving 6 reported U.S. cases of a rare & severe type of blood clot in individuals after receiving the vaccine. Right now, these adverse events appear to be extremely rare.
DaProphet,
For the second part regarding approximately 25% sale by TM and VM of their respective holdings, there are several reasons for it, but not insider dealing knowing that current forecast as you have wrote it.
I hope you know from this BB posted for other reasons behind the sale.
Hope this clarifies the matter.
bbrq648